Progesterone Not Working While TTC? What Research Shows
If progesterone was supposed to help, why haven't you gotten pregnant since starting it?
It's a fair, mechanistically reasonable question, not an overreaction. Vaginal progesterone concentrates locally in the uterus rather than strongly suppressing ovulation, which makes it a less likely culprit than when it is started relative to ovulation each cycle. The research picture is layered: the strongest benefit shown so far is in women with three or more prior losses who are bleeding in early pregnancy, while the only trial of progesterone in unmedicated natural cycles for unexplained infertility was too small to settle the question either way.
Why is secondary infertility with a "normal" workup its own frustrating category?
Secondary infertility — difficulty conceiving again after a prior successful pregnancy — deserves its own recognition, separate from primary infertility or recurrent loss more broadly. It carries a specific kind of confusion: a body that clearly worked before, a full round of testing that comes back normal, and no clean explanation for what changed. When early losses are part of that picture too, as they often are, the natural next step is progesterone support — but if conception itself stops happening after starting it, it is completely reasonable to wonder whether the treatment and the problem have gotten tangled together. It is one of the more common patterns we see in our Huntington practice, and one of the least satisfying to be handed a "nothing's wrong" on.
Can vaginal progesterone stop you from ovulating?
Progesterone taken vaginally has what's called a first uterine pass effect — it concentrates in uterine tissue at levels much higher than what shows up in the bloodstream, rather than circulating systemically the way an oral dose does. That matters here: strong suppression of the pituitary-ovarian axis (the signalling that governs whether and when ovulation happens) is associated more with oral or higher-dose systemic progestogens than with the vaginal route, which makes vaginal suppositories a comparatively less likely explanation for ovulation being disrupted.
Timing is the more plausible mechanism worth examining. If supplementation starts on a fixed day count each cycle rather than being adjusted to a confirmed ovulation marker (an LH surge or a basal body temperature shift), and actual ovulation timing varies from cycle to cycle, then starting progesterone before ovulation has happened is a biologically plausible way it could work against the process rather than support it. That is a concrete, answerable question to bring to your fertility specialist: is the start date tied to a confirmed ovulation signal, or to a fixed calendar day?
What does the established research on progesterone actually show?
The foundational work here is two large randomized trials, PROMISE (2015) and PRISM (2019), both published in the New England Journal of Medicine. PROMISE studied women with unexplained recurrent miscarriage; PRISM studied women with bleeding in early pregnancy. Neither found a statistically significant benefit overall — PRISM's live birth difference was about three percentage points, with a P value of .08.
What did emerge, in a prespecified subgroup analysis of PRISM published alongside a critical evaluation of both trials, was a clear benefit in a narrower group: women who had three or more previous miscarriages and were bleeding in the current pregnancy, where live birth was 72% with vaginal micronized progesterone versus 57% with placebo. That second condition matters and is often dropped when this finding gets quoted. Two prior losses, or three losses with no bleeding in the current pregnancy, sits outside the group where benefit is best established — which is context about the strength of the evidence, not a reason to think supplementation is working against you. Our pieces on whether low progesterone affects implantation and how to read a low 7 DPO progesterone with high prolactin cover the diagnostic side of interpreting progesterone results.
What does the newest research on progesterone in natural cycles show?
The PiNC trial, published in BJOG in 2025, is the first randomized controlled trial to test luteal phase progesterone supplementation in unmedicated natural cycles for unexplained infertility, rather than in a medicated IVF or IUI context. It randomized 143 couples to vaginal progesterone with timed intercourse or to timed intercourse alone for three cycles.
The results did not reach statistical significance at the trial's planned sample size, so it cannot be cited as proof that progesterone helps. It is worth noting which direction it pointed, though: live births and clinical pregnancies were numerically higher in the progesterone group, and the authors called the difference large enough to warrant a bigger trial. Nothing in it suggests that luteal progesterone in a natural cycle stops conception from happening. This is a genuinely unsettled, actively researched question — not a closed one in either direction.
What else is worth clarifying alongside the progesterone question?
One more distinction worth raising with a specialist: "not getting pregnant at all" over several months and "getting pregnant but losing it very early, before it would show on a home test" are different situations that can look identical from the outside, especially if testing has become less frequent since earlier losses. An early quantitative beta-hCG check in a future cycle can separate the two, and which one is actually happening meaningfully changes what the next step should be.
The bottom line
Vaginal progesterone's local mechanism makes it an unlikely direct cause of not conceiving, but the timing of when it starts relative to actual ovulation is a real and worth-asking-about possibility. The established evidence shows clear benefit in a specific group — three or more previous losses with bleeding in the current pregnancy — and the newest research on natural-cycle unexplained infertility has not yet given a definitive answer. This is a current, fair question to bring directly to your fertility specialist rather than work out alone at home. Here in Huntington, we see secondary infertility with a "nothing's wrong" workup often across Long Island and NYC, and untangling treatment timing from the underlying question is usually where real clarity starts. Our recurrent pregnancy loss care and unexplained infertility care pages explain how we work through a layered, still-unfolding history like this.
This article is for general educational purposes and isn't a substitute for individualized guidance from your reproductive endocrinologist or fertility specialist. Any change to progesterone supplementation or its timing should be made with your care team.
East to West Fertility is a metabolic and immune-focused fertility clinic in Huntington, Long Island, serving patients across Long Island, NYC, and beyond. Learn more about our Metabolic & Immune Fertility Evaluation or call 631-416-4940.
References:
- Coomarasamy A, et al. "A Randomized Trial of Progesterone in Women with Recurrent Miscarriages" (PROMISE). N Engl J Med, 2015.
- Coomarasamy A, et al. "A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy" (PRISM). N Engl J Med, 2019.
- Coomarasamy A, et al. "Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence." Am J Obstet Gynecol, 2020.
- Raperport C, et al. "Progesterone Luteal Support in Natural Cycles for Unexplained Infertility: A Randomised Controlled Trial (The PiNC Trial)." BJOG, 2025.
- "Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin." Fertility and Sterility.
